egtazic acid has been researched along with am 251 in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (53.33) | 29.6817 |
2010's | 7 (46.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kreitzer, AC; Regehr, WG | 1 |
Konishi, S; Rusakov, D; Saitow, F; Satake, S | 1 |
Beierlein, M; Regehr, WG | 1 |
Baimoukhametova, DV; Bains, JS; Oliet, SH; Piet, R | 1 |
Araque, A; Navarrete, M | 2 |
Hillard, CJ; Liu, QS; Pan, B | 1 |
Peña, JL; Penzo, MA | 1 |
Bains, JS; Kuzmiski, JB; Pittman, QJ | 1 |
Fujihara, H; Hashimoto, H; Nagatomo, T; Ohbuchi, T; Otsubo, H; Saito, T; Suzuki, H; Ueta, Y; Yokoyama, T | 1 |
Ali, AB; Todorova, M | 1 |
Castillo, PE; Chiu, CQ; Grandes, P; Puente, N | 1 |
Armstrong, WE; Wang, L | 1 |
Aceves, JJ; Bargas, J; Galarraga, E; Hernandez-Martinez, R; Rueda-Orozco, PE | 1 |
Becker, HC; Harlan, BA; Riegel, AC; Woodward, JJ | 1 |
15 other study(ies) available for egtazic acid and am 251
Article | Year |
---|---|
Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells.
Topics: Animals; Axonal Transport; Calcium; Cannabinoids; Egtazic Acid; Excitatory Postsynaptic Potentials; Hot Temperature; Kinetics; Neurotransmitter Agents; Piperidines; Purkinje Cells; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Receptors, GABA-B; Receptors, Metabotropic Glutamate; Receptors, Purinergic P1; Synapses | 2001 |
AMPA receptor-mediated presynaptic inhibition at cerebellar GABAergic synapses: a characterization of molecular mechanisms.
Topics: Action Potentials; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzothiadiazines; Benzoxazines; Calcium; Calcium Channel Blockers; Cerebellum; Chelating Agents; Colforsin; Cyclopropanes; Drug Interactions; Egtazic Acid; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Glycine; In Vitro Techniques; Morpholines; Naphthalenes; Neural Inhibition; Neurons; Piperidines; Presynaptic Terminals; Pyrazoles; Rats; Rats, Wistar; Receptors, AMPA; Ryanodine; Synapses; Triazines; Triazoles | 2004 |
Local interneurons regulate synaptic strength by retrograde release of endocannabinoids.
Topics: Action Potentials; Animals; Calcium Chloride; Calcium Signaling; Cannabinoid Receptor Modulators; Cerebellar Cortex; Egtazic Acid; Endocannabinoids; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Interneurons; Lipoprotein Lipase; Mice; Mice, Inbred C57BL; Mice, Knockout; Patch-Clamp Techniques; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Synapses; Synaptic Transmission | 2006 |
Retrograde regulation of GABA transmission by the tonic release of oxytocin and endocannabinoids governs postsynaptic firing.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzoxazines; Calcium; Cannabinoid Receptor Modulators; Egtazic Acid; Endocannabinoids; Extracellular Fluid; Female; gamma-Aminobutyric Acid; Hypothalamus, Anterior; Male; Morpholines; Naphthalenes; Oxytocin; Paraventricular Hypothalamic Nucleus; Patch-Clamp Techniques; Piperidines; Presynaptic Terminals; Pyrazoles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2007 |
Endocannabinoids mediate neuron-astrocyte communication.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Astrocytes; Calcium; Cannabinoid Receptor Modulators; Cell Communication; Egtazic Acid; Electric Stimulation; Endocannabinoids; Excitatory Amino Acid Antagonists; Glial Fibrillary Acidic Protein; Glutamic Acid; Hippocampus; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Patch-Clamp Techniques; Photolysis; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Type C Phospholipases; Valine | 2008 |
D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling.
Topics: Analysis of Variance; Animals; Animals, Newborn; Benzoxazines; Chromones; Cocaine; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Drug Combinations; Egtazic Acid; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; In Vitro Techniques; Long-Term Synaptic Depression; Male; Mesencephalon; Mice; Mice, Knockout; Morpholines; Naphthalenes; Neurons; Patch-Clamp Techniques; Piperidines; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Dopamine D2 | 2008 |
Endocannabinoid-mediated long-term depression in the avian midbrain expressed presynaptically and postsynaptically.
Topics: Animals; Biophysics; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cannabinoid Receptor Modulators; Chelating Agents; Chick Embryo; Egtazic Acid; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Excitatory Amino Acid Agents; Guanosine Diphosphate; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Long-Term Synaptic Depression; Mesencephalon; Methoxyhydroxyphenylglycol; Neurons; Patch-Clamp Techniques; Peptide Fragments; Pertussis Toxin; Piperidines; Presynaptic Terminals; Pyrazoles; Synapses; Thionucleotides | 2009 |
Metaplasticity of hypothalamic synapses following in vivo challenge.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Animals, Newborn; Biophysics; Carbolines; Clonidine; Down-Regulation; Drug Interactions; Egtazic Acid; Electric Stimulation; Excitatory Amino Acid Agents; Excitatory Postsynaptic Potentials; Glutamic Acid; Guanosine Diphosphate; Hypothalamus; In Vitro Techniques; Intracranial Hemorrhages; Long-Term Synaptic Depression; Male; Microinjections; Neurons; Patch-Clamp Techniques; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Metabotropic Glutamate; Synapses; Thionucleotides; Yohimbine | 2009 |
TRPV1 gene deficiency attenuates miniature EPSC potentiation induced by mannitol and angiotensin II in supraoptic magnocellular neurons.
Topics: Analysis of Variance; Angiotensin II; Anilides; Animals; Capsaicin; Chelating Agents; Cinnamates; Diuretics, Osmotic; Drug Interactions; Egtazic Acid; Enzyme Inhibitors; In Vitro Techniques; Male; Mannitol; Mice; Mice, Inbred C57BL; Mice, Knockout; Miniature Postsynaptic Potentials; Neurons; Piperidines; Pyrazines; Pyrazoles; Pyridines; Rats; Rats, Wistar; Signal Transduction; Supraoptic Nucleus; TRPV Cation Channels; Vasoconstrictor Agents | 2010 |
Asynchronous release of GABA via tonic cannabinoid receptor activation at identified interneuron synapses in rat CA1.
Topics: Animals; Animals, Newborn; Arachidonic Acids; CA1 Region, Hippocampal; Cannabinoid Receptor Modulators; Chelating Agents; Cholecystokinin; Dendrites; Egtazic Acid; Endocannabinoids; gamma-Aminobutyric Acid; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Interneurons; Lysine; Male; Neural Inhibition; Neural Pathways; Patch-Clamp Techniques; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Synapses | 2010 |
Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex.
Topics: Animals; Animals, Newborn; Benzoxazines; Cannabinoid Receptor Modulators; Chelating Agents; Dopamine; Dopamine Agents; Egtazic Acid; Endocannabinoids; Female; gamma-Aminobutyric Acid; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Isoquinolines; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron, Transmission; Morpholines; Naphthalenes; Neuronal Plasticity; Patch-Clamp Techniques; Piperidines; Prefrontal Cortex; Protein Kinase Inhibitors; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Dopamine D2; Silver Staining; Sulfonamides; Synapses | 2010 |
Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes.
Topics: Animals; Animals, Newborn; Astrocytes; Benzoates; Biophysics; Calcium; Cannabinoid Receptor Modulators; Chelating Agents; Drug Interactions; Egtazic Acid; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glycine; Hippocampus; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Knockout; Patch-Clamp Techniques; Photolysis; Piperidines; Pyramidal Cells; Pyrazoles; Pyridines; Receptor, Cannabinoid, CB1; Resorcinols; Synaptic Transmission; Thapsigargin | 2010 |
Tonic regulation of GABAergic synaptic activity on vasopressin neurones by cannabinoids.
Topics: Action Potentials; Animals; Arginine Vasopressin; Calcium; Cannabinoid Receptor Modulators; Dose-Response Relationship, Drug; Egtazic Acid; Female; GABAergic Neurons; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Neurons; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Vasopressins | 2012 |
Bidirectional plasticity in striatonigral synapses: a switch to balance direct and indirect basal ganglia pathways.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Basal Ganglia; Benzazepines; Benzoxazines; Biophysics; Cannabinoids; Chelating Agents; Corpus Striatum; Dopamine Agonists; Drug Interactions; Egtazic Acid; Electric Stimulation; Excitatory Amino Acid Antagonists; In Vitro Techniques; Long-Term Synaptic Depression; Male; Morpholines; Naphthalenes; Neural Pathways; Piperidines; Pyrazoles; Rats; Substantia Nigra; Synapses; Synaptic Transmission; Time Factors; Valine | 2011 |
Opposing actions of CRF-R1 and CB1 receptors on VTA-GABAergic plasticity following chronic exposure to ethanol.
Topics: Alcoholism; Animals; Benzoxazines; Central Nervous System Depressants; Corticotropin-Releasing Hormone; Dopaminergic Neurons; Egtazic Acid; Ethanol; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Male; Mice; Mice, Inbred C57BL; Morpholines; Naphthalenes; Neuronal Plasticity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Corticotropin-Releasing Hormone; Receptors, Presynaptic; Substance Withdrawal Syndrome; Ventral Tegmental Area | 2018 |